JPRN-UMIN000002887招募中未知
A multicenter study to examine renal protection by a combination of an HMG-CoA reductase inhibitor and losartan in patients with dyslipidemia associated with IgA nephropathy - LIPS study
Fukuoka University Faculty of Medicine0 个研究点目标入组 80 人开始时间: 2009年12月14日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with type 1 diabetes mellitus 2.Patients with cardiovascular disease and with the following conditions Patients who have undergone coronary artery bypass grafting (CABG) or percutaneous transluminal coronary angioplasty (PTCA) within the last 3 months, patients with unstable angina, patients with a history of myocardial infarction, patients with a history of a transient ischemic attack (TIA) within the last 6 months, patients that are NYHA functional class III or IV or with heart failure, and patients with a history of cerebral infarction within the last 3 months 3. serum Cr>2.5mg/dL or eGFR<30mL/min 4.Patients with severe liver dysfunction 5.Patients with secondary hypertension caused by factors other than diabetes mellitus 6.HbA1c > 9% 7.Patients with pregnancy or nursing 8.Other patients deemed ineligible by an investigator
研究者
相似试验
已完成
不适用
Multicenter study for the effect preserving renal function of HMG-CoA reductase inhibitor (simvastatin) in type 2 diabetic nephropathy with hyperlipidemia (MIDN Study)JPRN-C000000370Japanese Society of Kidney and Lipids200
已完成
不适用
An observational study of renal protection by intravenous amino acid therapy in abdominal aortic aneurysm surgeryabdominal aortic aneurysmJPRN-UMIN000038527ational Cerebral and Cardiovascular Center2,000
已完成
不适用
Examination of the effect of renal protection of aliskiren in chronic renal failure patient with hypertension (preservation period)Chronic renal failure patient with hypertension under going rennin-angiotensin treatment (ARB/ACE-inhibitor) (preservation period)JPRN-UMIN000002478Kure Kyousai Hospital200
进行中（未招募）
1 期
A multi-center study evaluating the safety of a replacement intravitreal fluocinolone acetonide (FA) (0.59 mg) implant in patients with non-infectious posterior uveitis who were previously treated with an intravitreal FA implantEUCTR2005-001589-15-GBBausch & Lomb Incorporated60
招募中
不适用
A clinical study to evaluate the effect of renal impairment of the pharmacokinetics of oral administration of Factive Tab. 320mgDiseases of the genitourinary systemKCT0006146Chonnam National University Hospital28